Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lameijer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Toxicology. Clinical Toxicology|June 24, 2000
Use of clonidine for chemical submissionK J Lusthof, W Lameijer, P G Zweipfenning
Pharmacy World & Science : PWS|August 1, 1996
Pharmaceutical analysis of the oral iron chelator deferiprone (DMHP,L1)R Lange, W Lameijer, C Slijkhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 14, 2001
Methodology for the development of a drug library based upon collision-induced fragmentation for the identification of toxicologically relevant drugs in plasma samplesA G Lips, W Lameijer, R H Fokkens, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 24, 2001
[Teaching to inhale: better utilization of powder inhalators after counseling and instruction]N E van 't Veer, W Lameijer, M De Ley, et al.
Therapeutic Drug Monitoring|January 19, 2006
Citalopram serum and milk levels in mother and infant during lactationE J F Franssen, V Meijs, F Ettaher, et al.
Annals of Hematology|November 1, 1996
Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (L1): a Dutch multicenter trialM J Kersten, R Lange, M E Smeets, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 14, 1988
Pharmacokinetics of intravenous and oral cyclophosphamide in the presence of methotrexate and fluorouracilE A De Bruijn, P H Slee, A T Van Oosterom, et al.
Bioinformatics (Oxford, England)|October 29, 2015
Detecting dispersed duplications in high-throughput sequencing data using a database-free approachM Kroon, E W Lameijer, N Lakenberg, et al.
Annals of the Rheumatic Diseases|April 19, 2014
A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosisYolande F M Ramos, Steffan D Bos, Ruud van der Breggen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Toxicology. Clinical Toxicology|June 24, 2000
Use of clonidine for chemical submissionK J Lusthof, W Lameijer, P G Zweipfenning
Pharmacy World & Science : PWS|August 1, 1996
Pharmaceutical analysis of the oral iron chelator deferiprone (DMHP,L1)R Lange, W Lameijer, C Slijkhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 14, 2001
Methodology for the development of a drug library based upon collision-induced fragmentation for the identification of toxicologically relevant drugs in plasma samplesA G Lips, W Lameijer, R H Fokkens, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 24, 2001
[Teaching to inhale: better utilization of powder inhalators after counseling and instruction]N E van 't Veer, W Lameijer, M De Ley, et al.
Therapeutic Drug Monitoring|January 19, 2006
Citalopram serum and milk levels in mother and infant during lactationE J F Franssen, V Meijs, F Ettaher, et al.
Annals of Hematology|November 1, 1996
Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (L1): a Dutch multicenter trialM J Kersten, R Lange, M E Smeets, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 14, 1988
Pharmacokinetics of intravenous and oral cyclophosphamide in the presence of methotrexate and fluorouracilE A De Bruijn, P H Slee, A T Van Oosterom, et al.
Bioinformatics (Oxford, England)|October 29, 2015
Detecting dispersed duplications in high-throughput sequencing data using a database-free approachM Kroon, E W Lameijer, N Lakenberg, et al.
Annals of the Rheumatic Diseases|April 19, 2014
A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosisYolande F M Ramos, Steffan D Bos, Ruud van der Breggen, et al.
Pageof 2